Merck Granted US Patents for Foundational CRISPR-Cas9 Technology
CRISPR technology is a core competency for Merck, which has 16 years’ experience with genome editing, spanning discovery to…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.